KemPharm Inc. (NASDAQ: KMPH) Attends 31st Annual ROTH Conference
KemPharm (NASDAQ: KMPH) is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LATTM (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm’s product pipeline is focused on the high need areas of ADHD, pain, and other central nervous system disorders. For more information, visit the company's website at www.kempharm.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content…







